{"id":7945,"date":"2019-10-10T13:23:54","date_gmt":"2019-10-10T17:23:54","guid":{"rendered":"https:\/\/www.med.unc.edu\/tarc\/?p=7945"},"modified":"2019-10-10T16:09:32","modified_gmt":"2019-10-10T20:09:32","slug":"dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/","title":{"rendered":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &#8220;Sprifermin&#8221;"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-7514\" src=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-259x300.jpg\" alt=\"\" width=\"259\" height=\"300\" srcset=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-259x300.jpg 259w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-768x888.jpg 768w, https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-886x1024.jpg 886w\" sizes=\"auto, (max-width: 259px) 100vw, 259px\" \/>An injection of the drug into the knee joints of people with OA increased cartilage thickness, compared to patients receiving placebo. However, pain and function did not improve.<\/p>\n<p>Over a 2-year period, patients who received sprifermin at the higher doses experienced statistically significant thickening of the cartilage; compared to patients receiving placebo, who instead experienced a reduction in cartilage.<\/p>\n<p>Dr. Loeser, who is a leading national osteoarthritis researcher, and director of the UNC Thurston Arthritis Research Center, told Medscape Medical News that while he was excited by the fact that the drug can thicken cartilage, it was disappointing that the secondary endpoint (improvement in pain and function) was not met.<\/p>\n<p>Nonetheless, Dr. Loeser noted that this is the first study to document a &#8220;benefit for structure in a really well-done clinical trial. That&#8217;s a breakthrough.&#8221;<\/p>\n<p>Dr. Loeser was not involved in the clinical trial.<\/p>\n<p>Learn more by reading the <a href=\"https:\/\/www.medscape.com\/viewarticle\/919690\">article published today in Medscape Medical News<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An injection of the drug into the knee joints of people with OA increased cartilage thickness, compared to patients receiving placebo. However, pain and function did not improve.<\/p>\n","protected":false},"author":58060,"featured_media":7514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"class_list":["post-7945","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &quot;Sprifermin&quot; | Thurston Arthritis Research Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &quot;Sprifermin&quot; | Thurston Arthritis Research Center\" \/>\n<meta property=\"og:description\" content=\"An injection of the drug into the knee joints of people with OA increased cartilage thickness, compared to patients receiving placebo. However, pain and function did not improve.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\" \/>\n<meta property=\"og:site_name\" content=\"Thurston Arthritis Research Center\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unctarc\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-10T17:23:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-10T20:09:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3543\" \/>\n\t<meta property=\"og:image:height\" content=\"4097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bradd Pavur\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UNCTARC\" \/>\n<meta name=\"twitter:site\" content=\"@UNCTARC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bradd Pavur\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\"},\"author\":{\"name\":\"Bradd Pavur\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf\"},\"headline\":\"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &#8220;Sprifermin&#8221;\",\"datePublished\":\"2019-10-10T17:23:54+00:00\",\"dateModified\":\"2019-10-10T20:09:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\"},\"wordCount\":171,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\",\"name\":\"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; \\\"Sprifermin\\\" | Thurston Arthritis Research Center\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg\",\"datePublished\":\"2019-10-10T17:23:54+00:00\",\"dateModified\":\"2019-10-10T20:09:32+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg\",\"width\":3543,\"height\":4097},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/tarc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &#8220;Sprifermin&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/\",\"name\":\"Thurston Arthritis Research Center\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/tarc\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf\",\"name\":\"Bradd Pavur\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5f0371dd0d493c316fd308b3d270d6f0d3343b21f2e07b4f9710e2cda81969dc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5f0371dd0d493c316fd308b3d270d6f0d3343b21f2e07b4f9710e2cda81969dc?s=96&d=mm&r=g\",\"caption\":\"Bradd Pavur\"},\"description\":\"Thurston Arthritis Res Center\",\"url\":\"https:\/\/www.med.unc.edu\/tarc\/author\/braddp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; \"Sprifermin\" | Thurston Arthritis Research Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; \"Sprifermin\" | Thurston Arthritis Research Center","og_description":"An injection of the drug into the knee joints of people with OA increased cartilage thickness, compared to patients receiving placebo. However, pain and function did not improve.","og_url":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/","og_site_name":"Thurston Arthritis Research Center","article_publisher":"https:\/\/www.facebook.com\/unctarc","article_published_time":"2019-10-10T17:23:54+00:00","article_modified_time":"2019-10-10T20:09:32+00:00","og_image":[{"width":3543,"height":4097,"url":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","type":"image\/jpeg"}],"author":"Bradd Pavur","twitter_card":"summary_large_image","twitter_creator":"@UNCTARC","twitter_site":"@UNCTARC","twitter_misc":{"Written by":"Bradd Pavur","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/"},"author":{"name":"Bradd Pavur","@id":"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf"},"headline":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &#8220;Sprifermin&#8221;","datePublished":"2019-10-10T17:23:54+00:00","dateModified":"2019-10-10T20:09:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/"},"wordCount":171,"image":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/","url":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/","name":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; \"Sprifermin\" | Thurston Arthritis Research Center","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/tarc\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","datePublished":"2019-10-10T17:23:54+00:00","dateModified":"2019-10-10T20:09:32+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#primaryimage","url":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","contentUrl":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","width":3543,"height":4097},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/tarc\/dr-richard-loeser-provides-expert-opinion-on-investigational-osteoarthritis-oa-drug-sprifermin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/tarc\/"},{"@type":"ListItem","position":2,"name":"Dr. Richard Loeser Provides Expert Opinion on Investigational Osteoarthritis (OA) Drug; &#8220;Sprifermin&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/tarc\/#website","url":"https:\/\/www.med.unc.edu\/tarc\/","name":"Thurston Arthritis Research Center","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/tarc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/6b9e44b7f1687f047ef8592213f6dbaf","name":"Bradd Pavur","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/tarc\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5f0371dd0d493c316fd308b3d270d6f0d3343b21f2e07b4f9710e2cda81969dc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5f0371dd0d493c316fd308b3d270d6f0d3343b21f2e07b4f9710e2cda81969dc?s=96&d=mm&r=g","caption":"Bradd Pavur"},"description":"Thurston Arthritis Res Center","url":"https:\/\/www.med.unc.edu\/tarc\/author\/braddp\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-259x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-768x888.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-886x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/tarc\/wp-content\/uploads\/sites\/802\/2019\/05\/Dr-Richard-Loeser_rtpsqsm2b-1-150x150.jpg","featured_image_alt":"","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/tarc\/category\/news\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/posts\/7945","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/users\/58060"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/comments?post=7945"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/posts\/7945\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/media\/7514"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/media?parent=7945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/categories?post=7945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/tarc\/wp-json\/wp\/v2\/tags?post=7945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}